To estimate hepatocellular carcinoma surveillance in the Medicaid cirrhotic population
OBJECTIVES: Surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma (HCC)...
Background: Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with...
Background: Surveillance for hepatocellular carcinoma (HCC) is recommended for patients with hepatit...
To estimate hepatocellular carcinoma surveillance in the Medicaid cirrhotic population
<p><b><i>Objective:</i></b> Hepatocellular carcinoma (HCC) is the second most common cause of cance...
: Patients with cirrhosis are advised to undergo hepatocellular carcinoma (HCC) surveillance every 6...
BackgroundSix-monthly hepatocellular carcinoma (HCC) screening in cirrhotic patients has been recomm...
Background: The minimal number of hepatocellular carcinoma (HCC) patients diagnosed through surveill...
A large proportion of patients with cirrhosis are seen only by their primary care provider (PCP). Su...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/148235/1/lt25398_am.pdfhttps://deepblu...
COMMENTARY ON:Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the ...
The incidence of hepatocellular carcinoma (HCC) in cirrhotic patients is increasing worldwide. Cirrh...
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cance...
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cance...
Hepatocellular carcinoma (HCC) is a common complication of cirrhosis. The incidence of HCC is rising...
OBJECTIVES: Surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma (HCC)...
Background: Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with...
Background: Surveillance for hepatocellular carcinoma (HCC) is recommended for patients with hepatit...
To estimate hepatocellular carcinoma surveillance in the Medicaid cirrhotic population
<p><b><i>Objective:</i></b> Hepatocellular carcinoma (HCC) is the second most common cause of cance...
: Patients with cirrhosis are advised to undergo hepatocellular carcinoma (HCC) surveillance every 6...
BackgroundSix-monthly hepatocellular carcinoma (HCC) screening in cirrhotic patients has been recomm...
Background: The minimal number of hepatocellular carcinoma (HCC) patients diagnosed through surveill...
A large proportion of patients with cirrhosis are seen only by their primary care provider (PCP). Su...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/148235/1/lt25398_am.pdfhttps://deepblu...
COMMENTARY ON:Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the ...
The incidence of hepatocellular carcinoma (HCC) in cirrhotic patients is increasing worldwide. Cirrh...
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cance...
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cance...
Hepatocellular carcinoma (HCC) is a common complication of cirrhosis. The incidence of HCC is rising...
OBJECTIVES: Surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma (HCC)...
Background: Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with...
Background: Surveillance for hepatocellular carcinoma (HCC) is recommended for patients with hepatit...